Insulin Lispro Recombinant is Used for managing diabetes, irritable bowel syndrome with diarrhea, and hyperglycemia. It was first introduced by Eli Lilly And Co in its drug Humalog on Jun 14, 1996. Other drugs containing Insulin Lispro Recombinant are Humalog Kwikpen, Humalog Pen, Humalog Tempo Pen. 2 different companies have introduced drugs containing Insulin Lispro Recombinant.

Insulin Lispro Recombinant Patents

Given below is the list of patents protecting Insulin Lispro Recombinant, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Humalog	US5474978	Insulin analog formulations	Jun 16, 2014 (Expired)	Lilly
Humalog	US5514646	Insulin analogs modified at position 29 of the B chain	May 07, 2013 (Expired)	Lilly
Humalog Kwikpen	US5474978	Insulin analog formulations	Jun 16, 2014 (Expired)	Lilly
Humalog Kwikpen	US5514646	Insulin analogs modified at position 29 of the B chain	May 07, 2013 (Expired)	Lilly
Humalog Kwikpen	US6034054	Stable insulin formulations	Jun 11, 2018 (Expired)	Eli Lilly And Co
Humalog Kwikpen	US6551992	Stable insulin formulations	Jun 11, 2018 (Expired)	Eli Lilly And Co
Humalog Kwikpen	US7291132	Medication dispensing apparatus with triple screw threads for mechanical advantage	Aug 09, 2024	Eli Lilly And Co
Humalog Kwikpen	US7291132	Medication dispensing apparatus with triple screw threads for mechanical advantage	Aug 09, 2024	Lilly
Humalog Pen	US5474978	Insulin analog formulations	Jun 16, 2014 (Expired)	Lilly
Humalog Pen	US5514646	Insulin analogs modified at position 29 of the B chain	May 07, 2013 (Expired)	Lilly

Add above patents to watchlist

Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳